MEDIC-NEST & BRIGHT conference on Precision Medicine & Digital Transformation

MEDIC-NEST and BRIGHT projects, funded by COSME Programme, will join forces and organise together the final conference of the two projects, in Brussels, Belgium, on the 24^th of January 2024!

The MEDIC-NEST team will focus on presenting the results of the project and on launching the European Meta-Cluster in Precision Medicine together with its strategic documents. The commonly organised conference will bring together relevant EU stakeholders and clusters representatives, seeking to define the synergies and the future initiatives.

MEDIC-NEST & BRIGHT Conference on Precision Medicine and Digital Transformation:

• 24^th of January 2024
• 10:30 AM – 16:00 PM
• CSIC (Consejo Superior de Investigaciones Científicas) Brussels Office
• Rue du Trône, 62. Brussels, Belgium

Main topics on the agenda:

• Presentation of the MEDIC-NEST and BRIGHT main outcomes
• Clusters’ role on the digital and sustainable transformation of the health ecosystems based on innovation. Panel session with EU stakeholders and cluster managers
• MEDIC-NEST projects generation workshop. Shaping together the perspectives on precision medicine
• Signature of the MEDIC-NEST Meta-Cluster Partnership Agreement and adhesions.

Please check the final agenda here 👉🏻 MEDIC NEST BRIGHT Final Conference Brussels Agenda and register for the conference, here 👉🏻 REGISTRATION OPEN

More about the MEDIC-NEST Meta Cluster in Precision Medicine

MEDIC NEST is a voluntary, open and agile alliance of European clusters and business supporting organisations strongly believing in the role of inter-cluster, cross border and cross sectoral collaboration supporting the internationalisation, growth and global competitiveness of the European Precision Medicine Ecosystem.

MEDIC NEST Meta Cluster founding members, IMAGO-MOL Cluster (Romania) MEDVIA (Belgium), Hellenic Bio Cluster (Greece) and SIVI Cluster (Spain), are keen to welcome under the Partnership Agreement the European clusters interested in commonly advance the development of precision medicine.